(19)
(11) EP 4 543 449 A1

(12)

(43) Date of publication:
30.04.2025 Bulletin 2025/18

(21) Application number: 23736005.2

(22) Date of filing: 23.06.2023
(51) International Patent Classification (IPC): 
A61K 31/502(2006.01)
A61K 35/00(2006.01)
A61P 35/00(2006.01)
A61K 31/555(2006.01)
A61K 45/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/502; A61K 45/06; A61K 31/555; A61P 35/00; A61K 31/519
 
C-Sets:
  1. A61K 31/502, A61K 2300/00;
  2. A61K 31/555, A61K 2300/00;
  3. A61K 31/519, A61K 2300/00;

(86) International application number:
PCT/EP2023/067153
(87) International publication number:
WO 2023/247769 (28.12.2023 Gazette 2023/52)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 24.06.2022 GB 202209285

(71) Applicant: BerGenBio ASA
5009 Bergen (NO)

(72) Inventor:
  • MCCRACKEN, Nigel
    5009 Bergen (NO)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) DOSAGE REGIMEN FOR AXL INHIBITOR